2023 Was a tricky 12 months for your biopharma business, with a number of corporations downsizing and restructuring their workforces to stay afloat. You will find indications of recovery, as mergers and acquisitions picked up through the pharmaceutical and everyday living sciences business inside the latter Section of 2023 and https://sites.google.com/view/bio-sites/blog